03 Profile
Who Professor Helena Teede is
Professor Helena Teede is Director of the Monash Centre for Health Research and Implementation (MCHRI) at Monash University in Melbourne, Australia, and an endocrinologist at Monash Health. MCHRI is a partnership between Monash University and Monash Health, and she established it and leads a cross-disciplinary team of more than 150 staff and students.
Her work covers women's health, including PCOS, pregnancy and menopause, as well as diabetes and metabolic health, and she focuses on turning research evidence into clinical practice and policy. She led the international evidence-based PCOS guideline and, with 56 patient and professional organisations including the UK charity Verity, the global process to rename PCOS as Polyendocrine Metabolic Ovarian Syndrome (PMOS). She argues that the old name contributed to missed diagnoses and inadequate treatment, because there is no increase in abnormal ovarian cysts and the condition's diverse features were often unappreciated.
She holds an Order of Australia for services to women's health.
Notable achievements
- 01
Led the process to rename PCOS as Polyendocrine Metabolic Ovarian Syndrome (PMOS), working with 56 patient and professional organisations, including Verity (PCOS UK). Source ↗
- 02
Chaired the international evidence-based guideline for the assessment and management of PCOS (2023 edition, titled PMOS). Source ↗
- 03
Elected Fellow of the Australian Academy of Health and Medical Sciences in 2017. The citation credits her with spearheading the world's first evidence-based PCOS guidelines. Source ↗
- 04
Holds an Order of Australia for services to women's health. She is a Fellow of the Royal Australasian College of Physicians, the Australian and NZ College of Obstetrics and Gynaecology, and the UK College of Obstetrics. Source ↗
- 05
Established MCHRI and was Executive Director of Monash Partners Academic Health Sciences Centre. She led the establishment of, and was inaugural chair of, the Australian Health Research Alliance and the National Women's Health Research Translation and Impact Network. Source ↗
Research & publications
Metformin in High Metabolic Risk Pregnancies — A Patient-Level Meta-Analysis
NEJM Evidence · 2026 · cited by 2
Lipidomic profiling reveals a distinct lipidomic signature of early gestational diabetes
Communications Medicine · 2026 · cited by 2
From PCOS to PMOS: perspectives on the new nomenclature – Authors’ reply
The Lancet · 2026 · cited by 1
Yearbook of pediatric endocrinology · 2026 · cited by 1
The Medical Journal of Australia · 2026 · cited by 0
PLoS Medicine · 2026 · cited by 0
BJOG An International Journal of Obstetrics & Gynaecology · 2026 · cited by 0
Diabetes Care · 2026 · cited by 0
Advances in Nutrition · 2026 · cited by 0
Computers in Biology and Medicine · 2026 · cited by 0
Frontiers in Public Health · 2026 · cited by 0
Cell Metabolism · 2026 · cited by 0
Acta Obstetricia Et Gynecologica Scandinavica · 2026 · cited by 0
Fertility and Sterility · 2026 · cited by 0
Endocrinology Diabetes & Metabolism · 2026 · cited by 0
The Medical Journal of Australia · 2026 · cited by 0
Journal of Internal Medicine · 2026 · cited by 0
American Journal of Obstetrics and Gynecology · 2026 · cited by 0
International Journal of Behavioral Nutrition and Physical Activity · 2026 · cited by 0
Hormone Research in Paediatrics · 2026 · cited by 0
European Journal of Endocrinology · 2026 · cited by 0
European Journal of Endocrinology · 2026 · cited by 0
Public Health · 2026 · cited by 0
Psychoneuroendocrinology · 2026 · cited by 0
Human Reproduction · 2026 · cited by 0
Publication records from OpenAlex and Europe PMC, matched on name and affiliation. Every entry links to its DOI so the attribution can be checked.





